Immune Response Mechanisms and Biological Properties of T-Cells and Circulating HSPCs: A Review

The immune system is a complex network of cells, tissues, and molecules that work together to protect the body against invading pathogens and maintain overall health. Two key components of the immune system, T-cells and circulating hematopoietic stem and progenitor cells (HSPCs), play critical roles in orchestrating immune responses and maintaining immune homeostasis [1]. Understanding the immune response mechanisms and biological properties of T-cells and circulating HSPCs is essential for comprehending the intricate workings of the immune system and developing novel strategies for immunotherapy and regenerative medicine [2]. T-cells, a subset of lymphocytes, are central players in adaptive immunity, the branch of the immune system responsible for recognizing and eliminating specific pathogens [3]. T-cells possess unique immune response mechanisms that enable them to mount targeted and effective immune responses. The antigen recognition process begins with the interaction between the T-cell receptor (TCR) on the surface of T-cells and specific antigens presented by antigen-presenting cells (APCs) [4]. This interaction triggers a series of signaling events, leading to T-cell activation, clonal expansion, and the differentiation of effector T-cell subsets. Different subsets of T-cells, such as helper T-cells (Th), cytotoxic T-cells (Tc), and regulatory T-cells (Treg), exhibit distinct functions in coordinating immune responses, eliminating pathogens, and maintaining immune tolerance [5].

Circulating HSPCs, on the other hand, are multipotent cells found in the bone marrow and peripheral blood. They have the remarkable ability to self-renew and differentiate into various blood cell lineages, including T-cells. HSPCs are responsible for continuously replenishing the pool of immune cells and ensuring the presence of a diverse immune repertoire [6]. Their mobilization from the bone marrow into the bloodstream, facilitated by cytokines and chemokines, allows for their collection and utilization in regenerative medicine and immunotherapeutic applications. Furthermore, the interactions between T-cells and HSPCs are intricate and reciprocal, with both cell types influencing each other’s development and function. HSPCs provide critical signals and support for T-cell development, particularly in the thymus, the primary site of T-cell maturation [7]. Understanding the immune response mechanisms and biological properties of T-cells and circulating HSPCs is crucial for advancing our knowledge of immune system function and developing innovative therapeutic strategies [8]. The knowledge gained from studying these cells has led to significant breakthroughs in immunotherapies, such as CAR T-cell therapy, which has revolutionized the treatment of certain cancers. Moreover, harnessing the regenerative potential of HSPCs holds promise for addressing immune-related disorders and improving patient outcomes following hematopoietic stem cell transplantation [9].

In this review, we will delve into the immune response mechanisms and biological properties of T-cells and circulating HSPCs, highlighting their significance in immune surveillance, immunotherapy and regenerative medicine. By exploring their intricate interactions and understanding their contributions to immune system function, we can pave the way for new avenues of research and therapeutic interventions in the field of immunology.

T-cell immune response mechanisms

T-cells, a type of lymphocyte, are central players in adaptive immunity. They possess several unique immune response mechanisms, including antigen recognition, activation, differentiation, and effector functions. T-cell receptors (TCRs) located on the surface of T-cells allow for specific recognition of antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs) [10]. This recognition triggers a cascade of signaling events, leading to T-cell activation and clonal expansion. Different subsets of T-cells, such as helper T-cells (Th), cytotoxic T-cells (Tc) and regulatory T-cells (Treg), exert distinct effector functions to eliminate pathogens, modulate immune responses, or maintain tolerance, respectively [11]. Furthermore, T-cells possess memory capabilities, enabling rapid and enhanced responses upon subsequent encounters with the same pathogen. The complex interplay of T-cell activation, differentiation, and effector functions forms the basis of adaptive immune responses [12].

Biological properties of circulating HSPCs

HSPCs are multipotent cells found in bone marrow and peripheral blood that give rise to various blood cell lineages, including T-cells. HSPCs possess unique biological properties that make them crucial for immune system function and regenerative medicine applications. These properties include self-renewal, multipotency and mobilization. Self-renewal allows HSPCs to continuously replenish the pool of stem and progenitor cells, ensuring a constant supply of immune cells [13]. The multipotency of HSPCs enables their differentiation into various cell lineages, including T-cells, B-cells, natural killer cells and myeloid cells, contributing to a diverse immune repertoire. HSPC mobilization, facilitated by cytokines and chemokines, allows for the release of HSPCs from the bone marrow into the bloodstream, facilitating their collection for transplantation or immunotherapeutic purposes [14].

Interactions between T-cells and HSPCs

The interactions between T-cells and HSPCs are complex and bidirectional. T-cells influence HSPCs through the secretion of cytokines and growth factors, modulating their proliferation, differentiation and migration. In turn, HSPCs influence T-cell development and function by providing critical signals and support [15]. Notably, the thymus, the primary site of T-cell development, relies on interactions with HSPCs for its proper function. HSPCs also play a crucial role in immune reconstitution following bone marrow transplantation, as they contribute to the generation of a new immune system [16].

Clinical applications and future perspectives

Understanding the immune response mechanisms and biological properties of T-cells and circulating HSPCs has significant implications for clinical applications. Manipulating T-cell responses and harnessing the regenerative potential of HSPCs have paved the way for immunotherapies, such as chimeric antigen receptor (CAR) T-cell therapy and hematopoietic stem cell transplantation [17]. These approaches have shown remarkable success in treating certain cancers and hematological disorders. Furthermore, ongoing research aims to enhance our understanding of the intricate interactions between T-cells and HSPCs, with the potential to develop novel therapies for immune-related diseases.

In conclusion, the immune response mechanisms and biological properties of T-cells and circulating HSPCs are integral to immune system function and hold significant clinical implications. Advancements in our understanding of these cell types have already transformed the landscape of immunotherapy and regenerative medicine. By continuing to explore their complexities, we can uncover new insights into immune responses, develop novel therapeutic strategies and ultimately improve the outcomes and quality of life for individuals with immune-related disorders.

The authors declare that they have no competing or any other financial interests.

All authors contributed equally to writing the manuscript.

This work wasn’t supported by any funding.

No acknowledgements for this article.

1. Granick JL, Simon SI, Borjesson DL (2012) Hematopoietic stem and progenitor cells as effectors in innate immunity. Bone Marrow Res 2012: 165107.
2. Cano RLE, Lopera HDE (2013) Introduction to T and B lymphocytes. In: Anaya JM, Shoenfeld Y, Rojas Villarraga A (Eds.), Autoimmunity: From Bench to Bedside. El Rosario University Press, Bogota, Colombia.
3. Janeway CA Jr, Travers P, Walport M (2001) Immunobiology: The immune system in health and disease. (5^th edn), Principles of innate and adaptive immunity, Garland Science, New York, USA.
4. Huang J, Meyer C, Zhu C (2012) T cell antigen recognition at the cell membrane. Mol Immunol 52(3-4): 155-164.
5. Kumar BV, Connors TJ, Farber DL (2018) Human T cell development, localization, and function throughout life. Immunity 48(2): 202-213.
6. Lee JY, Hong SH (2020) Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells 13(1): 1-12.
7. De Kruijf EFM, Fibbe WE, van Pel M (2020) Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche. Ann N Y Acad Sci 1466(1): 24-38.
8. Nicholson LB (2016) The immune system. Essays Biochem 60(3): 275-301.
9. Jogalekar MP, Rajendran RL, Khan F, Dmello C, Gangadaran P, et al. (2022) CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments. Front Immunol 13: 925985.
10. Janeway CA Jr, Travers P, Walport M (2001) Immunobiology: The immune system in health and disease. (5^th edn), Antigen recognition by T cells, Garland Science, New York, USA.
11. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
12. Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, et al. (2013) T cell responses: Naive to memory and everything in between. Adv Physiol Educ 37(4): 273-283.
13. Rieger MA, Schroeder T (2012) Hematopoiesis. Cold Spring Harb Perspect Biol 4(12): a008250.
14. Riether C, Schürch CM, Ochsenbein AF (2015) Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ 22(2): 187-198.
15. Cossío I, Lucas D, Hidalgo A (2019) Neutrophils as regulators of the hematopoietic niche. Blood 133(20): 2140-2148.
16. Thapa P, Farber DL (2019) The role of the thymus in the immune response. Thorac Surg Clin 29(2): 123-131.
17. Gschweng E, De Oliveira S, Kohn DB (2014) Hematopoietic stem cells for cancer immunotherapy. Immunol Rev 257(1): 237-249.